Ad is loading...
PHIO
Price
$2.21
Change
-$0.02 (-0.90%)
Updated
Nov 15 closing price
WVE
Price
$13.67
Change
-$1.33 (-8.87%)
Updated
Nov 15 closing price
102 days until earnings call
Ad is loading...

PHIO vs WVE

Header iconPHIO vs WVE Comparison
Open Charts PHIO vs WVEBanner chart's image
Phio Pharmaceuticals
Price$2.21
Change-$0.02 (-0.90%)
Volume$51.03K
CapitalizationN/A
Wave Life Sciences
Price$13.67
Change-$1.33 (-8.87%)
Volume$1.43M
CapitalizationN/A
PHIO vs WVE Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PHIO vs. WVE commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Sell and WVE is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PHIO: $2.21 vs. WVE: $13.67)
Brand notoriety: PHIO and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 64% vs. WVE: 65%
Market capitalization -- PHIO: $1.9M vs. WVE: $2.08B
PHIO [@Biotechnology] is valued at $1.9M. WVE’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, WVE is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 2 bullish TA indicator(s).

  • PHIO’s TA Score: 4 bullish, 6 bearish.
  • WVE’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than WVE.

Price Growth

PHIO (@Biotechnology) experienced а -25.08% price change this week, while WVE (@Biotechnology) price change was -16.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PHIO is expected to report earnings on May 11, 2023.

WVE is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($2.09B) has a higher market cap than PHIO($1.9M). WVE YTD gains are higher at: 170.693 vs. PHIO (-67.690). PHIO has higher annual earnings (EBITDA): -8.55M vs. WVE (-74.9M). WVE has more cash in the bank: 154M vs. PHIO (4.7M). PHIO has less debt than WVE: PHIO (0) vs WVE (28.9M). WVE has higher revenues than PHIO: WVE (110M) vs PHIO (0).
PHIOWVEPHIO / WVE
Capitalization1.9M2.09B0%
EBITDA-8.55M-74.9M11%
Gain YTD-67.690170.693-40%
P/E Ratio0.01N/A-
Revenue0110M-
Total Cash4.7M154M3%
Total Debt028.9M-
FUNDAMENTALS RATINGS
PHIO vs WVE: Fundamental Ratings
PHIO
WVE
OUTLOOK RATING
1..100
857
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9535
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (59) in the Biotechnology industry is in the same range as WVE (75). This means that PHIO’s stock grew similarly to WVE’s over the last 12 months.

PHIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WVE (100). This means that PHIO’s stock grew similarly to WVE’s over the last 12 months.

PHIO's SMR Rating (97) in the Biotechnology industry is in the same range as WVE (100). This means that PHIO’s stock grew similarly to WVE’s over the last 12 months.

WVE's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for PHIO (95). This means that WVE’s stock grew somewhat faster than PHIO’s over the last 12 months.

PHIO's P/E Growth Rating (76) in the Biotechnology industry is in the same range as WVE (100). This means that PHIO’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOWVE
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTI2.61-0.10
-3.69%
Ascent Solar Technologies Inc
HDSN5.95-0.23
-3.72%
Hudson Technologies
MCRB0.55-0.04
-7.16%
Seres Therapeutics
WVE13.67-1.33
-8.87%
Wave Life Sciences Ltd
GLOB203.29-25.50
-11.15%
Globant SA

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-0.90%
MTNB - PHIO
50%
Loosely correlated
-2.27%
TPST - PHIO
49%
Loosely correlated
-8.27%
IMNN - PHIO
39%
Loosely correlated
-3.66%
MDWD - PHIO
35%
Loosely correlated
-2.26%
BCYC - PHIO
33%
Loosely correlated
-3.50%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-8.87%
PRQR - WVE
44%
Loosely correlated
-3.29%
KRRO - WVE
40%
Loosely correlated
-4.31%
ATNF - WVE
35%
Loosely correlated
-6.72%
PHIO - WVE
34%
Loosely correlated
-0.90%
ABOS - WVE
32%
Poorly correlated
-8.05%
More